Envestnet Asset Management’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.41M | Sell |
18,816
-21,077
| -53% | -$2.7M | ﹤0.01% | 2696 |
|
2025
Q1 | $3.53M | Buy |
39,893
+7,778
| +24% | +$688K | ﹤0.01% | 2369 |
|
2024
Q4 | $2.8M | Buy |
32,115
+3,723
| +13% | +$325K | ﹤0.01% | 2486 |
|
2024
Q3 | $2.63M | Buy |
28,392
+5,707
| +25% | +$528K | ﹤0.01% | 2492 |
|
2024
Q2 | $2.44M | Sell |
22,685
-247
| -1% | -$26.6K | ﹤0.01% | 2475 |
|
2024
Q1 | $2.18M | Buy |
22,932
+603
| +3% | +$57.2K | ﹤0.01% | 2520 |
|
2023
Q4 | $2.06M | Buy |
22,329
+2,990
| +15% | +$276K | ﹤0.01% | 2453 |
|
2023
Q3 | $971K | Buy |
19,339
+3,496
| +22% | +$176K | ﹤0.01% | 2836 |
|
2023
Q2 | $1M | Buy |
15,843
+2,193
| +16% | +$139K | ﹤0.01% | 2744 |
|
2023
Q1 | $614K | Buy |
13,650
+489
| +4% | +$22K | ﹤0.01% | 3017 |
|
2022
Q4 | $577K | Sell |
13,161
-1,232
| -9% | -$54K | ﹤0.01% | 3019 |
|
2022
Q3 | $948K | Buy |
14,393
+521
| +4% | +$34.3K | ﹤0.01% | 2609 |
|
2022
Q2 | $701K | Buy |
13,872
+1,280
| +10% | +$64.7K | ﹤0.01% | 2860 |
|
2022
Q1 | $804K | Sell |
12,592
-1,393
| -10% | -$88.9K | ﹤0.01% | 2812 |
|
2021
Q4 | $1.5M | Sell |
13,985
-3,200
| -19% | -$343K | ﹤0.01% | 2352 |
|
2021
Q3 | $1.77M | Buy |
17,185
+678
| +4% | +$69.7K | ﹤0.01% | 2168 |
|
2021
Q2 | $1.45M | Buy |
16,507
+2,022
| +14% | +$178K | ﹤0.01% | 2282 |
|
2021
Q1 | $1.41M | Buy |
14,485
+2,461
| +20% | +$239K | ﹤0.01% | 2174 |
|
2020
Q4 | $1.35M | Buy |
12,024
+1,299
| +12% | +$146K | ﹤0.01% | 2010 |
|
2020
Q3 | $994K | Sell |
10,725
-4,577
| -30% | -$424K | ﹤0.01% | 2016 |
|
2020
Q2 | $1.19M | Buy |
+15,302
| New | +$1.19M | ﹤0.01% | 1863 |
|